A phase II study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in patients with colorectal cancer receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study)
Trial registration number and date of registration: This clinical trial is registered in the Japan Registry of Clinical Trials (jRCT) as jRCTs031220002).
Authors
- Narikazu Boku (ORCID: https://orcid.org/0000-0002-1438-707X)
- Masaaki Ishibashi
- Chieko Sasuga
- Naoki Furukawa
- Yuka Ahiko
- Satoko Monma
- Susumu Aikou
- Seiichiro Kuroda
- Dai Shida (ORCID: https://orcid.org/0000-0003-3294-1924)
- Masanori Nojima (ORCID: https://orcid.org/0000-0002-8788-2522)
- Naoki Sakuyama (ORCID: https://orcid.org/0000-0003-2711-1168)
- Yohei Iimura (ORCID: https://orcid.org/0000-0002-3473-8244)
- Keisuke Baba
Institutions
- Shiga University of Medical Science Hospital (JP)
- University of Tokyo Hospital (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- International Journal of Clinical Oncology
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1007/s10147-025-02857-4
- Citations
- 1
- Primary Topic
- Chemotherapy-related skin toxicity
- Type
- article
- Field-Weighted Citation Impact
- 2.00
Funders
- University of Tokyo